skillzMap and PharmaGenDRx Sign Strategic MoU to Accelerate Skill Development in the Pharmaceutical and Life Sciences Sector

Date:

Share post:

PharmaGenDRx, one of India’s emerging platforms dedicated to pharmaceutical education, industry engagement, and career development, has signed a Memorandum of Understanding (MoU) with SkillzMap, a leading skill development and learning solutions organization, to jointly strengthen industry-oriented education and workforce development across the pharmaceutical, biotechnology, healthcare, and life sciences sectors.

The strategic partnership aims to bridge the gap between academia and industry by offering structured upskilling, reskilling, and professional development programs that prepare students and working professionals for the evolving demands of the global healthcare ecosystem.

Under the MoU, PharmaGenDRx and SkillzMap will collaborate to design and deliver industry-focused certificate programs, executive education courses, workshops, webinars, masterclasses, boot camps, and hands-on training initiatives. The partnership will also focus on enhancing employability through internship opportunities, career guidance, industry mentorship, placement support, and networking with leading pharmaceutical organizations.

The collaboration will introduce specialized learning programs in key domains, including Clinical Research, Clinical Data Management, Pharmacovigilance, Regulatory Affairs, Medical Writing, Pharmaceutical Quality Assurance and Quality Control, Pharmaceutical Manufacturing, Medical Coding, Artificial Intelligence in Healthcare, Pharmaceutical Marketing, and other emerging areas of the life sciences industry.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...